RheumNow Podcast- Best Biologics (2.7.20)
Dr Jack Cush reviews the news and journal articles from the past week on RheumNow.com
Dr Jack Cush reviews the news and journal articles from the past week on RheumNow.com
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.
QD Clinic - Lessons from the clinic. In this video: Patients stable on a biologic need guidance on when, and if, they can stop their biologic. Features Dr. Jack Cush.
Dr. Jack Cush reviews the news from the past week on RheumNow.com, just in time for Christmas!
Dr. Jack Cush recaps the news and journal reports from the past week on RheumNow.com.
"Experience is a hard teacher, she give the test first then the lesson after." - Vernon Law.
I have been attending the ACR Review Course for more than a decade, and it seems every year it gets better and better. Contrary to what most people think, this is not a board review course; it is more of a review of the latest research delivered by experts condensing rheumatol
Shingrix (GSK), the herpes zoster subunit vaccine (a two-shot series), was approved by the FDA in Fall 2018 and is currently approved for use in adults 50 years and older.
Dr. Jack Cush recaps standout presentations and information from ACR 2019 held in Atlanta November 9-12, 2019.
Many rheumatic diseases affect women of childbearing age. In the age of biologic therapy, women are achieving better disease activity and there are increasing numbers of women with rheumatic diseases attempting pregnancy.
Here's my summary of key studies presented Tuesday.
Tofacitinib in Polyarticular JIA
TheDaoIndex @KDAO2011 ( View Tweet )
TheDaoIndex @KDAO2011 ( View Tweet )
Chris Wincup @chriswincup ( View Tweet )
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.